Abstract: Currently, more than 90% of small molecule new drug candidates have oral bioavailability issues. Solubility and bioavailability issues run through drug metabolism and pharmacokinetic evaluation of candidate compounds, preclinical prescription development, and commercial formulation development. Summary: A variety of industrially scalable and enhanced bioavailability drug delivery methods can be used to rapidly advance the formulation concept from milligram-level high-throughput experiments to production-level.References: https://www.formulationbio.com/encapsulation-techniques-services.html
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Virtual Patients Parallel Simulations in a Hybrid Cloud Environment
Ivan Borisov, Evgeny Metelkin, Tatiana Karelina, Oleg Demin
Wavefunction Stability Determination
Computational Planning of Synthesis of Natural Products
Neurodegeneration quantitative systems pharmacology modeling for analysis of multiple sclerosis therapy
Polina Pchelintseva, Anna Mishina, Tatiana Karelina
Retrosynthetic Route Planning Based on Molecular Similarity